308 related articles for article (PubMed ID: 32958755)
1. The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution.
Ballhausen A; Przybilla MJ; Jendrusch M; Haupt S; Pfaffendorf E; Seidler F; Witt J; Hernandez Sanchez A; Urban K; Draxlbauer M; Krausert S; Ahadova A; Kalteis MS; Pfuderer PL; Heid D; Stichel D; Gebert J; Bonsack M; Schott S; Bläker H; Seppälä T; Mecklin JP; Ten Broeke S; Nielsen M; Heuveline V; Krzykalla J; Benner A; Riemer AB; von Knebel Doeberitz M; Kloor M
Nat Commun; 2020 Sep; 11(1):4740. PubMed ID: 32958755
[TBL] [Abstract][Full Text] [Related]
2. The Immune Biology of Microsatellite-Unstable Cancer.
Kloor M; von Knebel Doeberitz M
Trends Cancer; 2016 Mar; 2(3):121-133. PubMed ID: 28741532
[TBL] [Abstract][Full Text] [Related]
3. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.
Schwitalle Y; Linnebacher M; Ripberger E; Gebert J; von Knebel Doeberitz M
Cancer Immun; 2004 Nov; 4():14. PubMed ID: 15563124
[TBL] [Abstract][Full Text] [Related]
4. Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors.
Roudko V; Bozkus CC; Orfanelli T; McClain CB; Carr C; O'Donnell T; Chakraborty L; Samstein R; Huang KL; Blank SV; Greenbaum B; Bhardwaj N
Cell; 2020 Dec; 183(6):1634-1649.e17. PubMed ID: 33259803
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
[TBL] [Abstract][Full Text] [Related]
6. A Genetic Vaccine Encoding Shared Cancer Neoantigens to Treat Tumors with Microsatellite Instability.
Leoni G; D'Alise AM; Cotugno G; Langone F; Garzia I; De Lucia M; Fichera I; Vitale R; Bignone V; Tucci FG; Mori F; Leuzzi A; Di Matteo E; Troise F; Abbate A; Merone R; Ruzza V; Diodoro MG; Yadav M; Gordon-Alonso M; Vanhaver C; Panigada M; Soprana E; Siccardi A; Folgori A; Colloca S; van der Bruggen P; Nicosia A; Lahm A; Catanese MT; Scarselli E
Cancer Res; 2020 Sep; 80(18):3972-3982. PubMed ID: 32690723
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
Gebert J; Gelincik O; Oezcan-Wahlbrink M; Marshall JD; Hernandez-Sanchez A; Urban K; Long M; Cortes E; Tosti E; Katzenmaier EM; Song Y; Elsaadi A; Deng N; Vilar E; Fuchs V; Nelius N; Yuan YP; Ahadova A; Sei S; Shoemaker RH; Umar A; Wei L; Liu S; Bork P; Edelmann W; von Knebel Doeberitz M; Lipkin SM; Kloor M
Gastroenterology; 2021 Oct; 161(4):1288-1302.e13. PubMed ID: 34224739
[TBL] [Abstract][Full Text] [Related]
8. A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial.
Kloor M; Reuschenbach M; Pauligk C; Karbach J; Rafiyan MR; Al-Batran SE; Tariverdian M; Jäger E; von Knebel Doeberitz M
Clin Cancer Res; 2020 Sep; 26(17):4503-4510. PubMed ID: 32540851
[TBL] [Abstract][Full Text] [Related]
9. Frameshift mutations of human gastrin receptor gene (hGARE) in gastrointestinal cancers with microsatellite instability.
Laghi L; Ranzani GN; Bianchi P; Mori A; Heinimann K; Orbetegli O; Spaudo MR; Luinetti O; Francisconi S; Roncalli M; Solcia E; Malesci A
Lab Invest; 2002 Mar; 82(3):265-71. PubMed ID: 11896205
[TBL] [Abstract][Full Text] [Related]
10. Frameshift-derived neoantigens constitute immunotherapeutic targets for patients with microsatellite-instable haematological malignancies: frameshift peptides for treating MSI+ blood cancers.
Maletzki C; Schmidt F; Dirks WG; Schmitt M; Linnebacher M
Eur J Cancer; 2013 Jul; 49(11):2587-95. PubMed ID: 23561850
[TBL] [Abstract][Full Text] [Related]
11. Detection of coding microsatellite frameshift mutations in DNA mismatch repair-deficient mouse intestinal tumors.
Woerner SM; Tosti E; Yuan YP; Kloor M; Bork P; Edelmann W; Gebert J
Mol Carcinog; 2015 Nov; 54(11):1376-86. PubMed ID: 25213383
[TBL] [Abstract][Full Text] [Related]
12. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
[TBL] [Abstract][Full Text] [Related]
13. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.
Linnebacher M; Gebert J; Rudy W; Woerner S; Yuan YP; Bork P; von Knebel Doeberitz M
Int J Cancer; 2001 Jul; 93(1):6-11. PubMed ID: 11391614
[TBL] [Abstract][Full Text] [Related]
14. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes.
Michel S; Linnebacher M; Alcaniz J; Voss M; Wagner R; Dippold W; Becker C; von Knebel Doeberitz M; Ferrone S; Kloor M
Int J Cancer; 2010 Aug; 127(4):889-98. PubMed ID: 20013806
[TBL] [Abstract][Full Text] [Related]
15. Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention.
Bolivar AM; Duzagac F; Deng N; Reyes-Uribe L; Chang K; Wu W; Bowen CM; Taggart MW; Thirumurthi S; Lynch PM; You YN; Rodriguez-Pascual J; Lipkin SM; Kopetz S; Scheet P; Lizee GA; Reuben A; Sinha KM; Vilar E
Gastroenterology; 2024 May; 166(5):787-801.e11. PubMed ID: 38244726
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability.
Ishikawa T; Fujita T; Suzuki Y; Okabe S; Yuasa Y; Iwai T; Kawakami Y
Cancer Res; 2003 Sep; 63(17):5564-72. PubMed ID: 14500396
[TBL] [Abstract][Full Text] [Related]
17. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors.
Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M
Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663
[TBL] [Abstract][Full Text] [Related]
18. An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopes.
Garbe Y; Maletzki C; Linnebacher M
PLoS One; 2011; 6(11):e26517. PubMed ID: 22110587
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability.
Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812
[TBL] [Abstract][Full Text] [Related]
20. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
